Fundraiser for Melanoma Research
Ten thousand dollars was raised for melanoma research at the Jennnifer’s Journey Melanoma Charity Ball held in Geelong on Saturday 12th October 2013. The sold out evening was put together…
Read More MRV Research
Longest Follow-Up Study Finds Ipilimumab Effective in Treating Melanoma
Melanoma is the most dangerous form of skin cancer and the leading cause of deaths due to skin disease. In a new study examining the life expectancy of melanoma patients, researchers found that a particular treatment option called ipilimumab was highly effective. According to the longest, follow-up study, melanoma patients that used ipilimumab can survive up to 10 years.
Exelixis Announces Presentation of Updated Phase 1b Data at ECC 2013
Exelixis Announces Presentation of Updated Phase 1b Data for Cobimetinib (GDC-0973/XL518) in Combination with Vemurafenib at ECC 2013
Immune drugs hold hope of “clinical cure" for deadly skin cancer
A new generation of drugs designed to trigger the immune system to fight cancer is offering the prospect of a “clinical cure" for some melanoma skin cancer patients who until a few years ago were more likely to be facing a swift death.